In the last two years, two BioSentinel payloads were launched to space. The ISS mission launched in December 2021, and returned to the ground in August 2022 after successfully completing eight biological experiments while validating the different instruments. On the other hand, the deep space mission launched onboard Artemis I in November 2022, and is currently in a heliocentric orbit over 20 million kilometers away from the Earth. Even though all hardware subsystems were validated in deep space, the microfluidic subsystems experienced anomalies throughout the initial 6-month mission. The main goals of this presentation are (1) to present flight data from the deep space payload, including biology, fluidics, electronics, data processing, and mission operations, and (2) to discuss the lessons learned – what worked and what did not – from this unique complex mission, and how these lessons are aiding in the development of the Lunar Exploration Instrument for space biology Applications (LEIA) mission, launching to the lunar surface on a commercial lander in 2026. As of the writing of this abstract, the satellite continues to work nominally, communicating to Earth via the Deep Space Network (DSN) twice per week. Importantly, the mission received and extension to continue recording data on the deep space radiation environment on its way to solar maximum (i.e., higher probability of solar particle events). BioSentinel is supported by NASA Exploration Systems Development Mission Directorate (ESDMD).
NASA's Biosentinel Mission: Lessons Learned and What's Next
2023
35 pages
Report
Keine Angabe
Englisch